Brenda Mann - Sep 2, 2021 Form 4 Insider Report for EYEGATE PHARMACEUTICALS INC (KPRX)

Role
VP of Research & Development
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Sep 2, 2021
Transactions value $
-$110
Form type
4
Date filed
9/3/2021, 04:15 PM
Previous filing
Aug 4, 2021
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -$110 -61 -0.4% $1.81 15.3K Sep 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 09/01/2021.